Spectroplast AG

Conventionally, silicone products are produced through liquid injection moulding, a process that is expensive, lengthy and wasteful, and is limited to mass production of identical parts. Spectroplast’s disruptive innovation provides the world’s first Silicone Additive Manufacturing (SAM) technology at industrial scale. SAM fulfils a longstanding market need for personalised silicone products and enables for the first time the production of mass customized end-use silicone products that perform identically to injection moulded parts for various markets ranging from general sealing solutions to life-saving medical implants, such as patient-specific heart valve replacements.